Ming-yang Tang

发表

Honokiol Ameliorates Post-Myocardial Infarction Heart Failure Through Ucp3-Mediated Reactive Oxygen Species Inhibition

Yan Liu, Heying Pei, Lijuan Chen, 2022, Frontiers in Pharmacology.

In vitro and in vivo metabolic profiling of PD105, a PI3Kδ inhibitor, using UHPLC-Q-Exactive Plus-MS.

Li Wan, Ming-yang Tang, Jiajia Zhao, 2023, Xenobiotica; the fate of foreign compounds in biological systems.

Discovery of pyrimidine-5-carboxamide derivatives as novel salt-inducible kinases (SIKs) inhibitors for inflammatory bowel disease (IBD) treatment.

Nannan Li, Lijuan Chen, Mingsong Shi, 2023, European journal of medicinal chemistry.

Discovery of indoline-based derivatives as effective ROCK2 inhibitors for the potential new treatment of idiopathic pulmonary fibrosis.

Yvonne Ying-Ya Wen, Yong Guo, Jie Kang, 2023, Bioorganic chemistry.

UPLC-MS/MS method development and application to pharmacokinetic study in rats and dogs of Flonoltinib Maleat.

Zhuang Yang, Qianlun Pu, Yanting Zhou, 2023, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Discovery and Evaluation of 3-Quinoxalin Urea Derivatives as Potent, Selective, and Orally Available ATM Inhibitors Combined with Chemotherapy for the Treatment of Cancer via Goal-Oriented Molecule Generation and Virtual Screening.

Dingguo Xu, T. Yang, Mingli Xiang, 2023, Journal of medicinal chemistry.

[Study of the Role and Mechanism of Asprosin/Spartin Pathway in Cardiac Microvascular Endothelial Injury Induced by Diabete Mellitus].

Juanni Hou, H. Pei, Sha Chen, 2019, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition.

NU6300 covalently reacts with cysteine-191 of gasdermin D to block its cleavage and palmitoylation

Ruijia Zhang, Ming-yang Tang, Min Zhao, 2024, Science advances.

Discovery of Potent, Specific, and Orally Available NLRP3 Inflammasome Inhibitors Based on Pyridazine Scaffolds for the Treatment of Septic Shock and Peritonitis.

Heying Pei, Yong Chen, Ming-yang Tang, 2024, Journal of medicinal chemistry.

Discovery of 4-amino-1,6-dihydro-7H-pyrrolo[2,3-d]pyridazin-7-one derivatives as potential receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitors.

Yong Li, Dexin Deng, Chufeng Zhang, 2023, European journal of medicinal chemistry.

Discovery, Optimization, and Evaluation of Potent and Selective DNA-PK Inhibitors in Combination with Chemotherapy or Radiotherapy for the Treatment of Malignancies.

Zhuang Yang, Yong Chen, Dexin Deng, 2023, Journal of medicinal chemistry.

Recent Progress and Prospects of Small Molecules for NLRP3 Inflammasome Inhibition.

Ruijia Zhang, Ming-yang Tang, Na Li, 2023, Journal of medicinal chemistry.

Discovery of Triazinone Derivatives as Novel, Specific, and Direct NLRP3 Inflammasome Inhibitors for the Treatment of DSS-Induced Ulcerative Colitis.

Nannan Li, Ruijia Zhang, Ming-yang Tang, 2023, Journal of medicinal chemistry.